3-(5-Bromo-3-methylpyridin-2-yl)-1-(2,4-difluorophenyl)thiourea

Catalog No. :
ACHGMX151
CAS No. :
306732-47-8
Molecular Formula :
C13H10BrF2N3S
Molecular Weight :
358.21

IUPAC Name:1-(5-bromo-3-methylpyridin-2-yl)-3-(2,4-difluorophenyl)thiourea

3-(5-Bromo-3-methylpyridin-2-yl)-1-(2,4-difluorophenyl)thiourea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(5-Bromo-3-methylpyridin-2-yl)-1-(2,4-difluorophenyl)thiourea
IUPAC Name1-(5-bromo-3-methylpyridin-2-yl)-3-(2,4-difluorophenyl)thiourea
MDL No.MFCD00169470
Molecular FormulaC13H10BrF2N3S
Molecular Weight358.21
SMILESS=C(NC1=NC=C(Br)C=C1C)NC2=CC=C(F)C=C2F
InChI KeyIOFZOIJTWGFFDU-UHFFFAOYSA-N
SynonymN-(5-BROMO-3-METHYL-2-PYRIDINYL)-N'-(2,4-DIFLUOROPHENYL)THIOUREA;3-(5-bromo-3-methylpyridin-2-yl)-1-(2,4-difluorophenyl)thiourea;Thiourea, N-(5-bromo-3-methyl-2-pyridinyl)-N'-(2,4-difluorophenyl)-
CAS No.306732-47-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHGMX151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZSQE089 route compound structure diagram
    ACZSQE0893430-21-5 In Stock
  2. Plus
  3. ACKPDA120 route compound structure diagram
    ACKPDA120141106-52-7 In Stock
  4. Then
  5. ACHGMX151 route product structure diagram
    ACHGMX151306732-47-8
Inquiry

2. ACHGMX151 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHGMX151 route product structure diagram
    ACHGMX151306732-47-8
Inquiry

Comments (0)